Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice
about
Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue DiseasePostnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in miceLocal and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaBConcentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory propertiesPertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed.Interleukin-11: a new cytokine critical for osteoclast developmentRegulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptorInterleukin 6 promotes murine lupus in NZB/NZW F1 mice.Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis.Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.IL-6 stimulates intestinal epithelial proliferation and repair after injury.Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse modelCytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic miceProtection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid.Loss of the polarity protein PAR3 activates STAT3 signaling via an atypical protein kinase C (aPKC)/NF-κB/interleukin-6 (IL-6) axis in mouse mammary cells.Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptidesAnti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia.Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock modelStudies of immunity and bacterial invasiveness in mice given a recombinant salmonella vector encoding murine interleukin-6.Interleukin-6 is required for a protective immune response to systemic Escherichia coli infectionInterleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock.Local cytokine production in a murine model of Escherichia coli pyelonephritisInterleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.Evidence for the involvement of interleukin 6 in experimental cancer cachexia.Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice.Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum.Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis.Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.KLHDC10 Deficiency Protects Mice against TNFα-Induced Systemic Inflammation.Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor.Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cellsDetection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing feverControl of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production.T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans
P2860
Q27490947-EA5A41AE-C176-45F5-A4C8-8993D142512AQ29617099-8F3833B6-2BF9-4955-ADC7-49DFECE2EBBBQ29619314-6CDB8BD4-1DB6-4671-8576-D958015976E2Q33494319-A4309124-63E1-4698-BF7E-FF38FEAA0912Q33608211-31FB96A7-5F4E-4BF4-9889-EA4E8CAC762AQ33610936-4CA41713-27B5-48E1-99F1-F060822EB746Q34138407-BBB5087D-958D-4A6C-A4A0-963A3192DA32Q34224435-BD0623C5-A7A8-4713-9B2A-373AFBC9B367Q34228814-A00BDE92-2D7B-4032-B68F-9827186213B7Q34521810-A8E8930B-8A73-4C18-BFB6-F68AFCCD9B91Q34529261-07406927-3CF8-44B6-A331-B119B828141CQ34529654-75BCF44A-A160-4B0E-A775-2832B67F92EDQ34640584-BCCC6009-6468-4407-9C8C-66CA03653852Q34742485-D5454412-E748-4B22-BAE5-B1012110BF37Q35196025-5F1C2FD1-9A29-4571-ACCD-8E13ED71CAC6Q35201746-50E40F60-A4AF-42B5-AE9A-723EBFD0B8ABQ35221604-C854C9D2-D96C-441B-A9BC-737A3E9822C8Q35378360-6BEB811C-DB76-4331-B2C4-FC447B25B40DQ35397408-28DAB1E6-BF0D-42D5-812D-9DBF5AD75000Q35417709-13ACA7CF-0D3A-4EBC-A3B9-18F9E35BFEF5Q35471377-E9D90980-CBDF-440A-9429-A441AC9C1527Q35505997-316E0F15-9C08-4FEE-903A-A6E95295FD84Q35512179-B37AB8B5-FAC2-4042-B8F0-A47206453669Q35544061-5EB3A696-23F0-4744-BDFE-365A3FDE47F7Q35558615-766F64CA-5A58-40E0-94F4-F804EC28CBCFQ35599824-1AD0985D-FFC0-4E14-A256-D4D6D22E439CQ35602202-2A9F76C1-3AF0-4F1F-9D82-7FC53AF211D1Q35602921-608A7615-AA62-4CEB-ABEA-F73AD19030E6Q35671570-B72F26C5-3898-4F0E-892E-DCBFC540D10CQ35831427-8A3829FD-0C5A-43C4-9254-05FFE6A682C4Q35897129-49D25DC4-4282-42DD-8D5A-58BC2F013186Q36029062-21420FB2-6D19-423B-B569-989DBEC900ABQ36134231-4FF5C99B-5599-4A6E-940B-5D8F10B0F3C3Q36231011-38D5765B-9BB0-4DAF-82BF-9EE3736D7EB5Q36231226-10EAD963-5F20-43F5-A13E-B3CDADD163CEQ36231303-ADE88AFF-C30E-453F-B2E4-BE12EEFEE121Q36276591-EA0B2649-FE6F-4D66-AD85-EC6683C13819Q36363056-D6C0E44C-68F1-4292-BE99-98DA14BD0F82Q36364968-22E847A9-5AFC-4180-97CD-E4724F9E49DBQ36366415-154C8A1D-7A09-468B-9C5E-C480B43D32D7
P2860
Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice
description
im Dezember 1990 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 1990
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1990
@uk
name
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@en
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@nl
type
label
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@en
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@nl
prefLabel
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@en
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@nl
P2093
P1476
Anti-IL-6 monoclonal antibodie ...... factor-alpha challenge in mice
@en
P2093
P304
P407
P577
1990-12-01T00:00:00Z